Patent · US Active

Polymorphic forms of RAD1901-2HCL

US11148996B2 · kind B2 · utility

1Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2020
Grant dateOct 19, 2021
Priority date
Expiry dateJul 6, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Various polymorphic forms of RAD1901-2HCl, including three crystalline and amorphous forms, are prepared and characterized. Uses of the various polymorphic forms of RAD1901-2HCl for cancer treatment are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.